Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer
Suneel K. Kamath, MD, et al investigated exceptional responders and the correlation of nonsynonymous mutations for patients with advanced pancreatic cancer.